News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Harvest Pharmaceuticals Inc. Release: Ergomar(R) Again Available To The Market


10/19/2005 5:10:49 PM

INDEPENDENCE, Va., Nov. 19 /PRNewswire/ -- Harvest Pharmaceuticals Inc has reintroduced Ergomar(R) Sublingual Tablets, 2 mg (ergotamine tartrate tablets, USP) to the marketplace after a manufacturing site change.

Ergomar(R) is indicated as therapy to abort or prevent migraine attacks.

Ergomar(R) Sublingual Tablets contain 2 mg of ergotamine tartrate and are supplied in individual foil strips packaged in a plastic, child resistant canister containing 20 tablets (5- 2 x 2 foil strips).

Harvest Pharmaceuticals Inc is a privately held corporation headquartered in Radford, Virginia. For further information, please telephone 888-374-6627.

Harvest Pharmaceuticals Inc

CONTACT: Steve Kirk of Harvest Pharmaceuticals Inc, +1-888-374-6627


Read at BioSpace.com

comments powered by Disqus
   
Migraine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES